India Launches Indigenous Td Vaccine
Analysis based on 22 articles · First reported Feb 20, 2026 · Last updated Feb 21, 2026
The launch of the indigenously manufactured Td vaccine by the India===Central Research Institute, Kasauli is positive for India's pharmaceutical and healthcare sectors, reinforcing its self-reliance goals. This event highlights India's growing capacity as a global vaccine manufacturer, potentially increasing investor confidence in its biotech industry.
Union Minister for Health and Family Welfare J. P. Nadda launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) Vaccine at the India===Central Research Institute, Kasauli in Himachal Pradesh. This launch is a significant step towards safeguarding India's national health security and strengthening its public health infrastructure, aligning with the vision of Atmanirbhar Bharat in health and medicine. The India===Central Research Institute, Kasauli will supply 55 lakh doses to the Universal Immunization Programme by April 2026, with production expected to scale up. India is recognized as the 'pharmacy of the world' and a leading vaccine manufacturer, having achieved Maturity Level 3 in the World Health Organization's global benchmarking of regulatory systems. The India===Central Research Institute, Kasauli is the first government institute to manufacture vaccines under Good Manufacturing Practices standards.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard